본문 바로가기
KERD
논문KCI 등재

Prescription of Systemic Steroids for Acute Respiratory Infections in Korean Outpatient Settings: Overall Patterns and Effects of the Prescription Appropriateness Evaluation Policy

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Objectives: The objective of this study was to identify individual and institutional factors associated with the prescription of systemic steroids in patients with acute respiratory infections and to investigate the role of a policy measure aimed to reduce inappropriate prescriptions. Methods: We used data from the National Health Insurance Service-National Sample Cohort from 2006 to 2015 and focused on episodes of acute respiratory infection. Descriptive analysis and multiple logistic regression analysis were performed to identify individual-level and institution-level factors associated with the prescription of systemic steroids. In addition, steroid prescription rates were compared with antibiotic prescription rates to assess their serial trends in relation to Health Insurance Review and Assessment Service (HIRA) Prescription Appropriateness Evaluation policy. Results: Among a total of 9 460 552 episodes of respiratory infection, the steroid prescription rate was 6.8%. Defined daily doses/1000 persons/d of steroid increased gradually until 2009, but rose sharply since 2010. The steroid prescription rate was higher among ear, nose and throat specialties (13.0%) than other specialties, and in hospitals (8.0%) than in tertiary hospitals (3.0%) and other types of institutions. Following a prolonged reduction in the steroid prescription rate, this rate increased since the HIRA Prescription Appropriateness Evaluation dropped steroids from its list of evaluation items in 2009. Such a trend reversal was not observed for the prescription rate of antibiotics, which continue to be on the HIRA Prescription Appropriateness Evaluation list. Conclusions: Specialty and type of institution are important correlates of steroid prescriptions in cases of acute respiratory infection. Steroid prescriptions can also be influenced by policy measures, such as the HIRA Prescription Appropriateness Evaluation policy.

Abstract

Objectives: The objective of this study was to identify individual and institutional factors associated with the prescription of systemic steroids in patients with acute respiratory infections and to investigate the role of a policy measure aimed to reduce inappropriate prescriptions. Methods: We used data from the National Health Insurance Service-National Sample Cohort from 2006 to 2015 and focused on episodes of acute respiratory infection. Descriptive analysis and multiple logistic regression analysis were performed to identify individual-level and institution-level factors associated with the prescription of systemic steroids. In addition, steroid prescription rates were compared with antibiotic prescription rates to assess their serial trends in relation to Health Insurance Review and Assessment Service (HIRA) Prescription Appropriateness Evaluation policy. Results: Among a total of 9 460 552 episodes of respiratory infection, the steroid prescription rate was 6.8%. Defined daily doses/1000 persons/d of steroid increased gradually until 2009, but rose sharply since 2010. The steroid prescription rate was higher among ear, nose and throat specialties (13.0%) than other specialties, and in hospitals (8.0%) than in tertiary hospitals (3.0%) and other types of institutions. Following a prolonged reduction in the steroid prescription rate, this rate increased since the HIRA Prescription Appropriateness Evaluation dropped steroids from its list of evaluation items in 2009. Such a trend reversal was not observed for the prescription rate of antibiotics, which continue to be on the HIRA Prescription Appropriateness Evaluation list. Conclusions: Specialty and type of institution are important correlates of steroid prescriptions in cases of acute respiratory infection. Steroid prescriptions can also be influenced by policy measures, such as the HIRA Prescription Appropriateness Evaluation policy.

참고문헌 (19)

  1. Lee YS, "Private practitioners’ antimicrobial prescription patterns for acute respiratory infections in children", J Korean Public Health Assoc, 17(2), pp.3~19 (1991)
  2. 김남순, "급성 상기도 질환에서 일차의료의사의 항생제 처방에 영향을 주는 요인", 예방의학회지, 38(1), pp.1~8 (2005), 대한예방의학회
  3. 조창익, "병원시장지역 내 경쟁 정도가 의원급 의료기관의 항생제 처방률에 미치는 영향", KDI Journal of Economic Policy, 30(2), pp.129~155 (2008), 한국개발연구원[DOI]
  4. Kim YI, "Health policy and management", pp.397~398 (2017), Seoul National University Press
  5. Evaluation project on appropriate prescribing report 2006, "Health Insurance Review and Assessment Service", Health Insurance Review and Assessment Service, 3~ (2007)
  6. 김신우, "성인의 상기도 감염", 대한의사협회지, 53(1), pp.10~19 (2010), 대한의사협회
  7. 김수영, "감기의 약물요법", 대한의사협회지, 58(2), pp.147~153 (2015), 대한의사협회[DOI]
  8. 김수경, "급성상기도감염 항생제 처방률 공개 효과 분석", 한국임상약학회지, 20(3), pp.242~247 (2010), 한국임상약학회
  9. 정광호, "정보공개제도가 항생제 처방에 미친 영향: 서울시 의료기관을 중심으로", 행정논총, 46(1), pp.123~150 (2008), 한국행정연구소
  10. 채수미, "외래 급성 상기도 감염에서의 항생제 사용량 및 약품비 추계", 약 학 회 지, 57(3), pp.199~204 (2013), 대한약학회
  11. 최원정, "급성상기도감염 환자의 항생제 처방에 영향을 주는 요인", 보건행정학회지, 25(4), pp.256~263 (2015), 한국보건행정학회
  12. 안중호, "급성 인두염의 보조적 치료제로서 단기간 경구 스테로이드의 효과", 대한이비인후-두경부외과학회지, 46(11), pp.971~974 (2003), 대한이비인후과학회
  13. 윤영경, "Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections", Infection and Chemotherapy, 49(4), pp.326~352 (2017), 대한감염학회
  14. Arroll B, "Antibiotics for the common cold and acute purulent rhinitis", Cochrane Database Syst Rev, (3), pp.CD000247~ (2005)
  15. Evaluation project on appropriate prescribing report, "Health Insurance Review and Assessment Service", Health Insurance Review and Assessment Service, 6~ (2009)
  16. 최은영, "급성기 뇌졸중 적정성 평가 결과의 분석", 보건의료기술평가, 5(1), pp.42~48 (2017), 한국보건의료기술평가학회[DOI]
  17. Hibbard JH, "Hospital performance reports: impact on quality, market share, and reputation", Health Aff (Millwood), 24(4), pp.1150~1160 (2005)
  18. Healy J, "Designing safer health care through responsive regulation", Med J Aust, 184(S10), pp.S56~S59 (2006)
  19. 윤효정, "외국의 성과연동지불제도 현황과 가감지급사업의 발전방향", 보건행정학회지, 27(2), pp.121~127 (2017), 한국보건행정학회

관련 논문AI추천

이 간행물의 다른 논문 (14건)